The Impact of Twice-Daily Indacaterol/Glycopyrrolate on the Components of Health-Related Quality of Life and Dyspnea in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease.

Mahler, Donald A; Kerwin, Edward; Murray, Lindsey; Dembek, Carole

Mahler, Donald A; Kerwin, Edward; Murray, Lindsey; Dembek, Carole.

Afiliación

Mahler DA; Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
Kerwin E; Clinical Research Institute of Southern Oregon, Medford, Oregon.
Murray L; Evidera, Bethesda, Maryland.
Dembek C; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts.

Chronic Obstr Pulm Dis ; 6(4)2019 Oct 23.

Article en En | MEDLINE | ID: mdl-31539467

Palabras clave

St George's Respiratory Questionnaire; Transition Dyspnea Index; chronic obstructive pulmonary disease; health-related quality of life; indacaterol/glycopyrrolate

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Chronic Obstr Pulm Dis Año: 2019 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google